JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Schneider National
SNDR
$5.66B
| $7.52M | ﹤0.01% |
263,417
-70,403
| -21% | -$1.82M |
2017 Q2
2 quarters
|
|
2252
PUT
Simon Property Group
SPG
$65B
| $7.52M | ﹤0.01% |
43,800
| – | – |
2017 Q2
2 quarters
|
|
2253
PUT
State Street
STT
$48B
| $7.52M | ﹤0.01% |
+77,000
| New | +$7.36M |
2017 Q4
0 quarters
|
|
|
ITCI
2254
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $7.49M | ﹤0.01% |
517,307
+108,882
| +27% | +$1.68M |
2017 Q3
1 quarter
|
|
|
CRC
2255
DELISTED
California Resources Corporation
CRC
| $7.48M | ﹤0.01% |
384,945
-20,153
| -5% | -$283K |
2014 Q4
12 quarters
|
|
|
KE
2256
Kimball Electronics
KE
$679M
| $7.48M | ﹤0.01% |
409,777
-16,873
| -4% | -$348K |
2014 Q4
12 quarters
|
|
2257
Advance Auto Parts
AAP
$2.34B
| $7.45M | ﹤0.01% |
74,767
+24,743
| +49% | +$2.28M |
2013 Q2
18 quarters
|
|
|
LGF.A
2258
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $7.44M | ﹤0.01% |
220,188
+118,369
| +116% | +$3.72M |
2016 Q4
4 quarters
|
|
2259
CALL
Air Products & Chemicals
APD
$60.9B
| $7.42M | ﹤0.01% |
45,200
+10,000
| +28% | +$1.59M |
2017 Q3
1 quarter
|
|
|
SHLM
2260
DELISTED
Schulman (A.) Inc
SHLM
| $7.39M | ﹤0.01% |
198,367
+92,920
| +88% | +$3.46M |
2013 Q2
18 quarters
|
|
2261
PUT
Freeport-McMoran
FCX
$99.5B
| $7.38M | ﹤0.01% |
389,500
+2,000
| +0.5% | +$30.2K |
2015 Q3
9 quarters
|
|
|
PXD
2262
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $7.38M | ﹤0.01% |
42,700
| – | – |
2017 Q1
3 quarters
|
|
2263
Interactive Brokers
IBKR
$38.9B
| $7.38M | ﹤0.01% |
498,224
-308,332
| -38% | -$4.2M |
2013 Q2
18 quarters
|
|
2264
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.58B
| $7.37M | ﹤0.01% |
66,872
-567,698
| -89% | -$62.9M |
2013 Q2
18 quarters
|
|
2265
TotalEnergies
TTE
$187B
| $7.36M | ﹤0.01% |
133,149
-33,753
| -20% | -$1.86M |
2013 Q2
18 quarters
|
|
|
TTPH
2266
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $7.36M | ﹤0.01% |
58,419
-1,546
| -3% | -$198K |
2017 Q3
1 quarter
|
|
|
CSRA
2267
DELISTED
CSRA Inc.
CSRA
| $7.36M | ﹤0.01% |
245,842
-51,085
| -17% | -$1.54M |
2015 Q4
8 quarters
|
|
|
CBM
2268
DELISTED
Cambrex Corporation
CBM
| $7.35M | ﹤0.01% |
153,135
-78,796
| -34% | -$3.9M |
2014 Q4
12 quarters
|
|
2269
CALL
JetBlue
JBLU
$1.57B
| $7.35M | ﹤0.01% |
329,000
| – | – |
2014 Q4
12 quarters
|
|
2270
CALL
Autodesk
ADSK
$44.2B
| $7.34M | ﹤0.01% |
+70,000
| New | +$8.16M |
2017 Q4
0 quarters
|
|
2271
CALL
Kohl's
KSS
$2.15B
| $7.33M | ﹤0.01% |
135,200
+105,200
| +351% | +$4.84M |
2017 Q3
1 quarter
|
|
2272
PUT
Yum! Brands
YUM
$37.3B
| $7.33M | ﹤0.01% |
89,800
+25,000
| +39% | +$1.98M |
2017 Q1
3 quarters
|
|
|
LM
2273
DELISTED
Legg Mason, Inc.
LM
| $7.32M | ﹤0.01% |
174,306
+45,768
| +36% | +$1.8M |
2013 Q2
18 quarters
|
|
2274
Element Solutions
ESI
$8.85B
| $7.3M | ﹤0.01% |
736,015
+47,817
| +7% | +$496K |
2015 Q4
8 quarters
|
|
|
BFS
2275
Saul Centers
BFS
$741M
| $7.28M | ﹤0.01% |
117,851
+11,180
| +10% | +$700K |
2013 Q2
18 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.